Monica Gandhi MD, MPH Profile picture
Mar 13, 2021 17 tweets 4 min read Read on X
Thread on transmission after vaccination without references since put in my previous thread- we may be determining our ideas on transmission after vax from rotavirus & other viruses without looking at unique features of SARS-CoV-2 & all the real world data we have:
While the clinical trials for the vaccines were not designed to assess whether vaccines reduced asymptomatic infection (and, thereby, transmission), there is biological plausibility that the antibodies and T-cell responses blocking symptomatic disease will also block asymptomatic
infection in the nasal passages. IgG immunoglobulins (generated and measured by the vaccine trials) enter the nasal mucosa. Moreover, SARS-CoV-2 vaccines also generate IgA (immunoglobulins at mucosa surface) which protect nasal passages from infection
researchsquare.com/article/rs-310…
Accumulating data from the real-world roll-out has also shown us vaccines reduce transmission. We tweeted these before- health-care workers in the United Kingdom who were swabbed every two weeks after vaccination demonstrated an 86 percent reduction in asymptomatic infection
compared with unvaccinated individuals. Health-care workers in Israel and across the Mayo Clinic system, show a similar result: a massive reduction in both symptomatic disease and asymptomatic infection after vaccination. A study from Israel with Ministry of Health data
showed that asymptomatic infection was reduced by 94% after two doses of the Pfizer vaccine (press release 3/11/21). A large study from vaccinated patients presenting for pre-surgical care at Mayo Clinics compared to unvaccinated showed an 80% reduction in asymptomatic infection
following mRNA vaccines. Another study from vaccinated HCWs in the UK show a four-fold reduction in asymptomatic infection with routine swabbing compared to unvaccinated HCWs after just 1 dose of the mRNA vaccine. Now, if you get exposed after vaccination, what are chances
you could be infectious to others? Nasal viral loads from post-vaccination exposures are low per two papers and likely noninfectious per CT values. Given that low nasal viral loads are the most important predictor of ability to transmit infection
thelancet.com/journals/lanin…
these lower nasal SARS-CoV-2 RNA levels in those vaccinated versus those unvaccinated portends well that forward transmission after vaccination will be rare. Therefore, asymptomatic surveillance testing after vaccination not indicated (which is why CDC said only quarantine after
exposure once vaccinated if you are symptomatic). And if you are exposed and testing indicated, would suggest rapid antigen test not PCR test as your viral load in nose could be low and not infectious given data above. academic.oup.com/cid/advance-ar…
WHAT SHOULD WE DO REGARDING TESTING AFTER VACCINATION? I wanted to add this query about testing on to this thread regarding transmission or asymptomatic infection after vaccination sine they are related. I have 2 threads on transmission reduction after vax - will try to merge
Based on CDC guidelines no need to quarantine after vax if asymptomatic & exposed, rec:
1) No asymptomatic surveillance after vaccination for COVID if exposed
2) If symptomatic, test but start with rapid antigen test to see if infectious
3) If positive on rapid, sequence strain
TRANSMISSION AFTER VACCINATION THREAD: Trying to add on to the same thread here about low rates of infection after vaccination (yes, even asymptomatic) since two new papers from NEJM today are relevant. We start with this table; many studies to date in real-world vaccines Image
massively decrease asymptomatic infection (which of course means reduce transmission). Implications: 1) vaccinated being around unvaccinated; 2) testing after vaccination if asymptomatic and whether public health resources should be used for that.1st paper
nejm.org/doi/full/10.10…
1st paper from University of Texas Southwestern Medical Center (UTSW). After vaccination, very difficult to get infected, figure here. % of persons who became infected differed according to vaccination status: infections in 234 of 8969 nonvaccinated employees (2.61%), 112 of 6144 Image
partially vaccinated employees (1.82%) & 4 of 8121 fully vaccinated employees (0.05%). Gives credence to CDC rec that health care workers need not quarantine after exposure if asymptomatic (and low chance of COVID-19 even if symptomatic). 2nd paper
nejm.org/doi/full/10.10…
During surge in Southern California among HCWs while getting vaccine. Rare to test positive (asymptomatic swabs) after 2nd dose of vaccine (7/4167) 0.01% so even during surge with exposure (HCWs), hard to test positive after vaccination meaning very protective vaccine.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Monica Gandhi MD, MPH

Monica Gandhi MD, MPH Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MonicaGandhi9

Aug 30, 2023
HOW LONG DOES IMMUNITY LAST? To COVID vaccines or infection? We do not really know but there have been some really nice papers lately that give us more information. Please remember immunity divided into antibodies (which can come down & not work as well against variants)
IgA is one in the nose & mouth ("mucosa") that is raised by shots (vaccines) to certain extent but rise higher after natural infection; IgG is the one that is "humoral" or in the bloodstream. Many threads on here about cellular-mediated immunity: B & T cells cover all variants
This recent preprint is really important and summarized by @florian_krammer below in depth. Main take-aways: Breakthrough infections induce IgA (we knew) but protection from vaccine long-lasting even against former variants to severe disease/mortality
Read 8 tweets
May 3, 2023
RSV VACCINE FOR OLDER ADULTS: Respiratory syncytial virus (RSV) respiratory virus (most common after flu pre-COVID). 2 subtypes, A&B (1 dominates/season). Droplet; Recurrent infections. Most severe in neonates & adults >65; FDA approves 1st RSV vax today
msn.com/en-us/news/us/…
RSV vaccine 3 trials of new RSV vaccine, all published in the @NEJM recently so just to keep them straight- here is the vaccine which just got approved May 3 by the FDA for older adults. Remember our T/B cells so protection against severe disease higher!
nejm.org/doi/full/10.10…
A single dose of the RSVPreF3 OA vaccine had an acceptable safety profile and prevented RSV-related severe respiratory illness by 94% in adults>=60 years (71% against RSV infection, likely to fall with time as antibodies fall but severe disease protection will remain)
Read 4 tweets
Mar 21, 2023
NASAL VACCINES: To explain nasal vaccines, we have to explain the immune system first.
IgA is an antibody that helps attack the pathogen and exists in mucosal surfaces (like nose/mouth)
IgG is an antibody that is in the bloodstream
bbc.com/news/world-asi…
Cellular immunity is fantastic, redundant (so even if one cell line down in immunocompromised, have other), generated by either vaccine or infection; Comprised of
T cells- so in breadth from vax - works even across spike protein with its mutations
And the 2nd type of cell produced by vaccines or infection -B cell- amazing thing about B cells is that - if see omicron or one of its subvariants in future- they make antibodies adapted to that variant or subvariant (aided by T cells); adaptive immunity
Read 15 tweets
Mar 15, 2023
PUBLIC HEALTH POLICY: Seem to be at reckoning phase of COVID response- what worked, what didn't. Which interventions will be used in future pandemic responses? Interventions asked of public need good medical evidence for them (e.g. RCTs preferably, systematic reviews) to impose
In our field, Cochrane reviews represent best way to sum up the medical evidence to date by performing meta-analyses or systemic reviews of currently-available data; here is Cochrane on masks & other interventions for respiratory viruses including COVID
cochranelibrary.com/cdsr/doi/10.10…
Many asked past 3 years how CDC developed policies on masks (& age to mask), distancing (feet), ventilation, schools-> all non-pharmaceutical interventions. Originally theory-based. Now 3 years in, have data (RCTs highest level) to form policies from both US and other countries
Read 4 tweets
Mar 6, 2023
VACCINE DISCRIMINATION: We need to stop vaccine requirements for US entry like almost every other country. Am finishing COVID chapter for our ID "bible" & vaccines prevented transmission early on with alpha, but not enough now with current variants to justify such discrimination
Moreover, shame, stigma, blame (remember COVIDiots?), coercion, discrimination not good public health tools. When used for HIV, public health & ID physicians decried them but tactics used a lot in COVID. This book tries to explore & correct that for future
barnesandnoble.com/w/endemic-moni…
Concept of #harmreduction in pandemic responses means watching carefully if vulnerable people (like students, older people, low-income populations, migrants, sex workers, prisoners, those with disabilities, refugees, minorities) harmed more by response
nature.com/articles/s4146…
Read 4 tweets
Feb 8, 2023
FEAR: Some media & public health officials concerned Americans aren't fearful of COVID now. But the vaccines & therapeutics DO WORK. If we can't celebrate biomedical advances & imbibe their effectiveness (we have better tools for COVID than flu), what is point of developing?
In HIV medicine, when therapies came out, we didn't say to people- stay fearful; make this the controlling principle of your life. The book #Endemic I wrote (coming out July 11, 2023) hails these biomedical advances & the age we are in to fight pandemics to reassure the world
This is a rather brilliant summary of the issue from @benryanwriter
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(